Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 17, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2025
Self-assembled nickel(II)-centered metal-organic square grid complexes for CO2 sensing.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: April 02, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2024
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 22, 2024
Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort.
Journal: Cardio-oncology (London, England)
Published: September 05, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 01, 2024
Clonal Hematopoiesis Is Associated With Cardiomyopathy During Solid Tumor Therapy.
Journal: JACC. CardioOncology
Published: January 01, 2024
Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations.
Journal: The oncologist
Published: December 08, 2023
Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis.
Journal: The Journal of antimicrobial chemotherapy
Published: January 13, 2023
A bridge too far? Distance to waivered physicians and utilization of buprenorphine treatment for opioid use disorder in West Virginia Medicaid.
Journal: Substance abuse
Published: January 31, 2022
Last Updated: 09/26/2026